LFVN

LIFEVANTAGE CORP

Consumer Defensive | Micro Cap

$0.14

EPS Forecast

$46.64

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
KPTIKaryopharm Therapeutics IncCPRXCatalyst Pharmaceuticals IncANIPAni Pharmaceuticals IncEOLSEvolus IncOVIDOvid Therapeutics Inc